BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25819487)

  • 1. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of human serum albumin binding for drug leads.
    Vallianatou T; Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2013 May; 8(5):583-95. PubMed ID: 23461733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of a PAMPA model to predict passive gastrointestinal absorption and plasma protein binding.
    Bujard A; Voirol H; Carrupt PA; Schappler J
    Eur J Pharm Sci; 2015 Sep; 77():273-8. PubMed ID: 26118348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals.
    Müller C; Farkas R; Borgna F; Schmid RM; Benešová M; Schibli R
    Bioconjug Chem; 2017 Sep; 28(9):2372-2383. PubMed ID: 28898054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of drug-binding strengths to human serum albumin.
    Colmenarejo G
    Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding.
    Zhu XW; Sedykh A; Zhu H; Liu SS; Tropsha A
    Pharm Res; 2013 Jul; 30(7):1790-8. PubMed ID: 23568522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on binding of drug to serum protein].
    Otagiri M
    Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.
    Gleeson MP
    J Med Chem; 2007 Jan; 50(1):101-12. PubMed ID: 17201414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective binding of chiral drugs to plasma proteins.
    Shen Q; Wang L; Zhou H; Jiang HD; Yu LS; Zeng S
    Acta Pharmacol Sin; 2013 Aug; 34(8):998-1006. PubMed ID: 23852086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective protein binding of tetrahydropalmatine enantiomers in human plasma, HSA, and AGP, but not in rat plasma.
    Sun DL; Huang SD; Wu PS; Li J; Ye YJ; Jiang HD
    Chirality; 2010 Jun; 22(6):618-23. PubMed ID: 19927376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.
    Gokara M; Kimavath GB; Podile AR; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(1):196-210. PubMed ID: 24359035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
    Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
    J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
    Chen L; Chen X
    J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.
    Ascoli GA; Domenici E; Bertucci C
    Chirality; 2006 Sep; 18(9):667-79. PubMed ID: 16823814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the retention behavior of structurally diverse drugs on alpha(1) acid glycoprotein column: insight on the molecular factors involved and correlation with protein binding data.
    Chrysanthakopoulos M; Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
    Eur J Pharm Sci; 2014 Aug; 60():24-31. PubMed ID: 24800938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The drug binding site of human alpha1-acid glycoprotein: insight from induced circular dichroism and electronic absorption spectra.
    Zsila F; Iwao Y
    Biochim Biophys Acta; 2007 May; 1770(5):797-809. PubMed ID: 17321687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.